Patent ID: 7998671

Claim:
A method of detecting a risk of developing prostate cancer in an individual, comprising: a) genotyping a biological sample from the individual to determine the identity of a combination of three BAP28-related biallelic markers (BM) or the complements thereof, said combination of three BAP28-related biallelic markers being the allele combination of TAT at biallelic markers A53, A51 and A34; and b) detecting the presence of the allele combination of TAT at biallelic markers A53, A51 and A34 in said biological sample as indicative of a risk of developing prostate cancer in said individual, said biallelic markers being located at the following positions: nucleotide 402 in SEQ ID NO: 26 (A53); nucleotide 278 in SEQ ID NO: 24 (A51); and nucleotide 71993 in SEQ ID NO: 1 (A34), wherein the T of the A34 biallelic marker is the complement of the A depicted at nucleotide 71993 in SEQ ID NO: 1.